India approves first dengue vaccine QDENGA for 4-60 age group
The story in brief
India's Drug Controller General approved QDENGA, the country's first dengue vaccine, for use in people aged 4-60. The tetravalent, live-attenuated vaccine, effective against all four dengue serotypes, showed 84.1% efficacy in preventing hospitalisations after 4.5 years. Approved in 43 countries, it has distributed over 32 million doses globally and is safe, well-tolerated, and immunogenic across age groups.